BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12665117)

  • 1. Buprenorphine: new pharmacological aspects.
    Cowan A
    Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine: considerations for pain management.
    Johnson RE; Fudala PJ; Payne R
    J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
    Yu G; Yue YJ; Cui MX; Gong ZH
    J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine-induced hyperalgesia in the rat.
    Wala EP; Holtman JR
    Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of opioid receptor occupancy of buprenorphine in vivo.
    Englberger W; Kögel B; Friderichs E; Strassburger W; Germann T
    Eur J Pharmacol; 2006 Mar; 534(1-3):95-102. PubMed ID: 16490191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine: a primer for emergency physicians.
    Sporer KA
    Ann Emerg Med; 2004 May; 43(5):580-4. PubMed ID: 15111917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation.
    Mégarbane B; Marie N; Pirnay S; Borron SW; Gueye PN; Risède P; Monier C; Noble F; Baud FJ
    Toxicol Appl Pharmacol; 2006 May; 212(3):256-67. PubMed ID: 16169027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling.
    Ohtani M; Kotaki H; Sawada Y; Iga T
    J Pharmacol Exp Ther; 1995 Feb; 272(2):505-10. PubMed ID: 7853163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current knowledge of buprenorphine and its unique pharmacological profile.
    Pergolizzi J; Aloisi AM; Dahan A; Filitz J; Langford R; Likar R; Mercadante S; Morlion B; Raffa RB; Sabatowski R; Sacerdote P; Torres LM; Weinbroum AA
    Pain Pract; 2010; 10(5):428-50. PubMed ID: 20492579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
    Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.
    Kress HG
    Eur J Pain; 2009 Mar; 13(3):219-30. PubMed ID: 18567516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.